Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas

OBJECTIVE: Previous studies evaluating the effect of metformin on cancer risk have been impacted by time-related biases. To avoid these biases, we examined the incidence of bladder cancer in new users of metformin and sulfonylureas (SUs). RESEARCH DESIGN AND METHODS: This cohort study included 87,60...

Descripción completa

Detalles Bibliográficos
Autores principales: Mamtani, Ronac, Pfanzelter, Nick, Haynes, Kevin, Finkelman, Brian S., Wang, Xingmei, Keefe, Stephen M., Haas, Naomi B., Vaughn, David J., Lewis, James D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067396/
https://www.ncbi.nlm.nih.gov/pubmed/24496803
http://dx.doi.org/10.2337/dc13-1489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067396/
https://www.ncbi.nlm.nih.gov/pubmed/24496803
http://dx.doi.org/10.2337/dc13-1489

Ejemplares similares